Cargando…

Prolylcarboxypeptidase Alleviates Hypertensive Cardiac Remodeling by Regulating Myocardial Tissue Angiotensin II

BACKGROUND: Prolonged activation of angiotensin II is the main mediator that contributes to the development of heart diseases, so converting angiotensin II into angiotensin 1‐7 has emerged as a new strategy to attenuate detrimental effects of angiotensin II. Prolylcarboxypeptidase is a lysosomal pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nguyen, Binh Y., Zhou, Fangchao, Binder, Pablo, Liu, Wei, Hille, Susanne S., Luo, Xiaojing, Zi, Min, Zhang, Hongyuan, Adamson, Antony, Ahmed, Fozia Z., Butterworth, Sam, Cartwright, Elizabeth J., Müller, Oliver J., Guan, Kaomei, Fitzgerald, Elizabeth M., Wang, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356030/ https://www.ncbi.nlm.nih.gov/pubmed/37318028 http://dx.doi.org/10.1161/JAHA.122.028298

Ejemplares similares

Prolylcarboxypeptidase (PRCP) as a new target for obesity treatment
por: Shariat-Madar, B, et al.
Publicado: (2010)

Pak2 Regulation of Nrf2 Serves as a Novel Signaling Nexus Linking ER Stress Response and Oxidative Stress in the Heart
por: Binder, Pablo, et al.
Publicado: (2022)

Targeting mir128-3p alleviates myocardial insulin resistance and prevents ischemia-induced heart failure
por: Ruiz-Velasco, Andrea, et al.
Publicado: (2020)

Prolylcarboxypeptidase Mitigates Myocardial Ischemia/Reperfusion Injury by Stabilizing Mitophagy
por: Hao, Panpan, et al.
Publicado: (2020)

Upregulation of prolylcarboxypeptidase (PRCP) in lipopolysaccharide (LPS) treated endothelium promotes inflammation
por: Ngo, My-Linh, et al.
Publicado: (2009)

Structural definition and substrate specificity of the S28 protease family: the crystal structure of human prolylcarboxypeptidase
por: Soisson, Stephen M, et al.
Publicado: (2010)

Genetic association study of prolylcarboxypeptidase polymorphisms with susceptibility to essential hypertension in the Yi minority of China: A case–control study based on an isolated population
por: Wu, Yanrui, et al.
Publicado: (2020)

Prolylcarboxypeptidase promotes IGF1R/HER3 signaling and is a potential target to improve endocrine therapy response in estrogen receptor positive breast cancer
por: Duan, Lei, et al.
Publicado: (2022)

Pak2 as a Novel Therapeutic Target for Cardioprotective Endoplasmic Reticulum Stress Response
por: Binder, Pablo, et al.
Publicado: (2019)

CCAAT/enhancer‐binding protein β overexpression alleviates myocardial remodelling by regulating angiotensin‐converting enzyme‐2 expression in diabetes
por: Tie, Yuanyuan, et al.
Publicado: (2017)

Angiotensin receptor-neprilysin inhibitors and cardiac remodeling
por: Ryazanov, A.S., et al.
Publicado: (2023)

The Renin-Angiotensin-Aldosterone System in Vascular Inflammation and Remodeling
por: Pacurari, Maricica, et al.
Publicado: (2014)

Molecular remodeling of the renin-angiotensin system after kidney transplantation
por: Antlanger, Marlies, et al.
Publicado: (2017)

Neohesperidin Protects Angiotensin II-Induced Hypertension and Vascular Remodeling
por: Zhang, Jingsi, et al.
Publicado: (2022)

Puerariae lobatae Radix Alleviates Pre-Eclampsia by Remodeling Gut Microbiota and Protecting the Gut and Placental Barriers
por: Huang, Liping, et al.
Publicado: (2022)

Recent Advances on Drug Development and Emerging Therapeutic Agents Through Targeting Cellular Homeostasis for Ageing and Cardiovascular Disease
por: Azam, Tayyiba, et al.
Publicado: (2022)

Angiotensin-converting enzyme genetic polymorphism: its impact on cardiac remodeling
por: de Albuquerque, Felipe Neves, et al.
Publicado: (2014)

Pressure-overload-induced angiotensin-mediated early remodeling in mouse heart
por: Kim, Jeremy H., et al.
Publicado: (2017)

The Impact of microRNAs in Renin–Angiotensin-System-Induced Cardiac Remodelling
por: Adamcova, Michaela, et al.
Publicado: (2021)

Farrerol prevents Angiotensin II-induced cardiac remodeling in vivo and in vitro
por: He, Jian, et al.
Publicado: (2023)

PMCA4 inhibition does not affect cardiac remodelling following myocardial infarction, but may reduce susceptibility to arrhythmia
por: Stafford, Nicholas, et al.
Publicado: (2021)

Reduced expression of PMCA1 is associated with increased blood pressure with age which is preceded by remodelling of resistance arteries
por: Little, Robert, et al.
Publicado: (2017)

Pioglitazone Improves Potassium Channel Remodeling Induced by Angiotensin II in Atrial Myocytes
por: Gu, Jun, et al.
Publicado: (2014)

Folic Acid Mitigates Angiotensin-II-Induced Blood Pressure and Renal Remodeling
por: Pushpakumar, Sathnur B., et al.
Publicado: (2013)

Adventitial gene transfer of catalase attenuates angiotensin II-induced vascular remodeling
por: LIU, CUN-FEI, et al.
Publicado: (2015)

Angiotensin-(1–7) attenuates atrial tachycardia-induced sympathetic nerve remodeling
por: Shangguan, Wenfeng, et al.
Publicado: (2017)

Role of c-Abl and nephrin in podocyte cytoskeletal remodeling induced by angiotensin II
por: Ma, Yiqiong, et al.
Publicado: (2018)

Nox2 in regulatory T cells promotes angiotensin II–induced cardiovascular remodeling
por: Emmerson, Amber, et al.
Publicado: (2018)

Effects of the Angiotensin‐Receptor Neprilysin Inhibitor on Cardiac Reverse Remodeling: Meta‐Analysis
por: Wang, Yiwen, et al.
Publicado: (2019)

Loss of Apelin Augments Angiotensin II-Induced Cardiac Dysfunction and Pathological Remodeling
por: Sato, Teruki, et al.
Publicado: (2019)

Angiotensin Receptor‐Neprilysin Inhibition Attenuates Right Ventricular Remodeling in Pulmonary Hypertension
por: Sharifi Kia, Danial, et al.
Publicado: (2020)

Regional and temporal progression of atrial remodeling in angiotensin II mediated atrial fibrillation
por: Jansen, Hailey J., et al.
Publicado: (2022)

Interleukin‐38 alleviates cardiac remodelling after myocardial infarction
por: Wei, Yuzhen, et al.
Publicado: (2019)

Mica Can Alleviate TNBS-Induced Colitis in Mice by Reducing Angiotensin II and IL-17A and Increasing Angiotensin-Converting Enzyme 2, Angiotensin 1-7, and IL-10
por: Shen, Mengdie, et al.
Publicado: (2020)

Impaired Glutathione Redox System Paradoxically Suppresses Angiotensin II-Induced Vascular Remodeling
por: Izawa, Kazuma, et al.
Publicado: (2014)

Deficiency of Nox2 prevents angiotensin II-induced inward remodeling in cerebral arterioles
por: Chan, Siu-Lung, et al.
Publicado: (2013)

Effect of Lysyl Oxidase Inhibition on Angiotensin II-Induced Arterial Hypertension, Remodeling, and Stiffness
por: Eberson, Lance S., et al.
Publicado: (2015)

Role of MicroRNAs in Renin-Angiotensin-Aldosterone System-Mediated Cardiovascular Inflammation and Remodeling
por: Pacurari, Maricica, et al.
Publicado: (2015)

C-type natriuretic peptide prevents angiotensin II-induced cardiac remodelling and dysfunction
por: Roloff, Konstanze, et al.
Publicado: (2015)

Angiotensin II Type 1 Receptor-Mediated Electrical Remodeling in Mouse Cardiac Myocytes
por: Kim, Jeremy, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_4vo6vcdv82nmu820phn8t0kbvu